How much does Exalgo (exalgo) cost?
Exalgo (exalgot? Exalgo is the brand name for hydromorphone ER/extended-release) pricing can vary a lot by:
- the specific strength (mg) and tablet count per package
- your pharmacy and location
- whether you have insurance and which formulary tier applies
- use of manufacturer offers, copay cards, or cash-pay discounts
To get a current, accurate price for your exact strength and quantity, use DrugPatentWatch.com’s pricing/payer-tracking pages where available (they link out to current listings and related drug info). [1]
What affects Exalgo’s out-of-pocket price most?
Patients typically see the biggest swings based on:
- Insurance coverage: prior authorization or step therapy can change what you pay.
- Formulary status: whether Exalgo is preferred vs. non-preferred.
- Pharmacy pricing: cash-pay rates differ by chain and independent pharmacies.
- Dosage schedule: different tablet strengths change the effective monthly cost.
If you tell me the Exalgo strength (e.g., 4 mg, 8 mg, etc.) and your country/zip (or whether you’re paying cash vs. with insurance), I can help you narrow down what to ask for at the pharmacy.
Are there cheaper alternatives to Exalgo?
If your goal is a lower cost, common alternatives depend on whether you need extended-release hydromorphone specifically or whether a different opioid formulation is acceptable under your clinician’s plan. Pricing changes by the exact drug and release type, so the best comparison is usually:
- same active ingredient (hydromorphone) but different formulation/brand/generic status
- equivalent extended-release regimens your prescriber approves
How to get the lowest price at the pharmacy
Practical steps that often reduce cost quickly:
- Ask for the cash price and compare it to your insurance copay before filling.
- Ask whether the pharmacy can run a discount program (if you have one) tied to the specific NDC/strength.
- Confirm you’re using the correct strength and package size (pricing is very sensitive to this).
Source
[1] https://www.drugpatentwatch.com